Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems


J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   

spp11 - aggressive bladder tumors1 - early kidney damage1 - squamous cell carcinoma1 - phosphorus1 - lut1 - congenital malformations1 - renal fibrosis1 - syphilis1 - birth control pills1 - kidney recipients1 - kallmann's syndrome1 - neisseria gonorrhoeae2 - docetaxel1 - pulmonary hypoplasia1 - menstrual cycle1 - depression2 - the american society of nephrology3 - molecular markers1 - prostate cancer care1 - dependence1 - vascular calcification1 - kidney pelvis1 - hyperglycemia1 - robotic-assisted surgery1 - ureteropelvic stone1 - glycosuria1 - harvard medical school2 - antibiotic resistance1 - hepatolenticular degeneration1 -